Neuroendocrine tumors of the urinary bladder – Report of two cases
Meenakshi Rao; Apoorvi Dubey; Himanshu Pandey; Binit Sureka; Pawan Kumar Garg; Harishkumar Bohra; Poonam Elhence
Abstract
Keywords
References
1 Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumors of the urinary system and male genital organs 4th ed. Lyon: IARC; 2016. p. 117-19.
2 Menon S, Goyal P, Suryawanshi P, et al. Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas. Indian J Pathol Microbiol. 2014;57(1):19-23.
3 Al-Zahrani AA. Recurrent urinary bladder Paraganglioma. Adv Urol. 2010;2010:912125.
4 Zhou M, Epstein JI, Young RH. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens. Am J Surg Pathol. 2004;28(1):94-100.
5 Blomjos CE, Vos W, Voogt HJ, Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer. 1989;64(6):1347-57.
6 Sehgal SS, Wein AJ, Bing Z, Malkowicz SB, Guzzo TJ. Neuroendocrine tumor of the bladder. Rev Urol. 2010;12(4):e197-201. PMid:21234264.
7 Mukesh M, Cook N, Hollingdale AE, Ainsworth NL, Russell SG. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int. 2009;103(6):747-52.
8 Jones TD, Kernek KM, Yang XJ, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol. 2005;36(7):718-23.
Submitted date:
03/02/2021
Accepted date:
06/06/2021
Publication date:
08/20/2021